Navigation Links
Authors of landmark study on infant mortality and electronic medical records receive Garfield Award
Date:11/15/2012

Alexandria, VA November 15, 2012The authors of a landmark study on the use of electronic medical records (EMRs) to reduce infant mortality will receive the 2012 Garfield Economic Impact Award. Amalia R. Miller, PhD, and Catherine E. Tucker, PhD, are being honored for their paper, "Can Health Care Information Technology Save Babies?" The award, presented by Research!America, recognizes economists whose work contributes to our understanding of the ways in which medical and health research and new, research-based technologies and treatments impact the economy. The award is supported by a grant from Merck & Co., Inc.

The study, published in Journal of Political Economy, provides solid evidence that creating an electronic rather than a paper interface between patient information and health care providers reduces neonatal mortality. They further demonstrated that the cost of EMRs used for this purpose is minimal when measured against the societal benefits.

"The research that underlies increasingly sophisticated health IT, including electronic medical records, is an important facet of research for health. We applaud Drs. Miller and Tucker for demonstrating in such concrete terms the value of research-based EMRs in meeting a crucial societal goal," said Mary Woolley, president and CEO, Research!America. "Further, by demonstrating the modest cost of the use of the technology per life saved, they have made a strong economic case for investing in the research to develop similar health care tools."

The findings are particularly important given that the U.S. has struggled for years to reduce infant mortality rates, according to the paper. Each year, 18,000 babies die in the United States within their first 28 days of life. According to the authors, this high rate of neonatal mortality means that the United States is ranked 43rd in the world and lags behind 24 of the 27 members of the European Union.

"Evaluating the cost effectiveness of medical innovation in actual practice has been challenging," said Mark McClellan, MD, PhD, director, Engelberg Center for Health Care Reform, Brookings Institution, and a Research!America Board member. "This important research uses creative methods to overcome the challenges and provide important new evidence on cost effectiveness of electronic medical records."

Using a 12-year county-level panel, the authors found that EMRs reduced neonatal mortality by 16 deaths per 100,000 live births. The authors credit this decrease to the fact that EMRs facilitate fast and accurate access to patient records, which improves diagnosis and patient monitoring.

Miller and Tucker will be honored at a reception at the American Association for the Advancement of Science (AAAS) building in Washington, DC, on Thursday, November 15, 2012. The reception is preceded by a post-election panel discussion about the outlook for medical research and innovation.


'/>"/>

Contact: Anna Briseno
abriseno@researchamerica.org
571-482-2737
Research!America
Source:Eurekalert

Related medicine news :

1. Elsevier congratulates its British Medical Association award winning medical authors and editors
2. Jeffrey W. Olin, DO, authors study that describes symptoms and severity of fibromuscular dysplasia
3. Landmark HIV treatment-as-prevention study shows additional health benefits, cost-effectiveness
4. Landmark textbook on health care and the US legal system released
5. Scientists rewrite rulebook on breast cancer in landmark global study
6. Study Tracks Brain Gene Response to Territorial Aggression
7. Study shows different approach after progression in non-small cell lung cancer patients
8. Study reveals insights that could aid in therapeutic use of mesenchymal stem cells
9. Alcoholic Drinks Add 100 Calories a Day to Average Adults Diet: Study
10. Cash cuts increase smoking death risk for worlds poor, study says
11. Study finds asthma is not linked to lower educational attainment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: